Targeting Residual Inflammatory Risk: A Shifting Paradigm for Atherosclerotic Disease

Aday, AW; Ridker, PM

Aday, AW (reprint author), Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med,Vanderbilt Translat & Clin Car, Nashville, TN USA.

FRONTIERS IN CARDIOVASCULAR MEDICINE, 2019; 6 ():

Abstract

As biologic, epidemiologic, and clinical trial data have demonstrated, inflammation is a key driver of atherosclerosis. Circulating biomarkers of infl......

Full Text Link